Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment

The past two decades have brought many important advances in our understanding of the hereditary susceptibility to cancer. Numerous studies have provided convincing evidence that identification of germline mutations associated with hereditary cancer syndromes can lead to reductions in morbidity and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PeerJ
Main Authors: Vysotskaia, Valentina S., Hogan, Gregory J., Gould, Genevieve M., Wang, Xin, Robertson, Alex D., Haas, Kevin R., Theilmann, Mark R., Spurka, Lindsay, Grauman, Peter V., Lai, Henry H., Jeon, Diana, Haliburton, Genevieve, Leggett, Matt, Chu, Clement S., Iori, Kevin, Maguire, Jared R., Ready, Kaylene, Evans, Eric A., Kang, Hyunseok P., Haque, Imran S.
Formato: Artigo
Idioma:Inglês
Publicado em: PeerJ Inc. 2017
Assuntos:
Genomics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5326550/
https://ncbi.nlm.nih.gov/pubmed/28243543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.3046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados